129 related articles for article (PubMed ID: 9723126)
1. Neuroethological assessment of amphetamine-induced behavioral changes and their reversal by neuroleptics: focus on the amygdala and nucleus accumbens.
Wang Z; Rebec GV
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):883-905. PubMed ID: 9723126
[TBL] [Abstract][Full Text] [Related]
2. Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine.
Wang Z; Rebec GV
Brain Res; 1996 Mar; 711(1-2):64-72. PubMed ID: 8680876
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
Renard J; Loureiro M; Rosen LG; Zunder J; de Oliveira C; Schmid S; Rushlow WJ; Laviolette SR
J Neurosci; 2016 May; 36(18):5160-9. PubMed ID: 27147666
[TBL] [Abstract][Full Text] [Related]
4. Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Obuchowicz E; Herman ZS
Neuropeptides; 2003 Feb; 37(1):17-24. PubMed ID: 12637031
[TBL] [Abstract][Full Text] [Related]
5. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
Meng ZH; Feldpaush DL; Merchant KM
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):39-50. PubMed ID: 9795122
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei.
O'Dell LE; Sussman AN; Meyer KL; Neisewander JL
Neuropsychopharmacology; 1999 Jun; 20(6):591-602. PubMed ID: 10327428
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
8. Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.
Pierce RC; Clemens AJ; Shapiro LA; Rebec GV
Psychopharmacology (Berl); 1994 Sep; 116(1):103-9. PubMed ID: 7862921
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the glutamate transporter by L-trans-PDC in the nucleus accumbens prevents the locomotor response to amphetamine.
David HN; Thévenoux A; Abraini JH
Neuropharmacology; 2001 Sep; 41(3):409-11. PubMed ID: 11522333
[TBL] [Abstract][Full Text] [Related]
10. REM sleep deprivation produces a motivational deficit for food reward that is reversed by intra-accumbens amphetamine in rats.
Hanlon EC; Benca RM; Baldo BA; Kelley AE
Brain Res Bull; 2010 Oct; 83(5):245-54. PubMed ID: 20619322
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral baclofen administration decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum.
Zhou W; Mailloux AW; McGinty JF
Neuropsychopharmacology; 2005 May; 30(5):880-90. PubMed ID: 15592348
[TBL] [Abstract][Full Text] [Related]
12. CART peptide 55-102 microinjected into the nucleus accumbens inhibits the expression of behavioral sensitization by amphetamine.
Kim S; Yoon HS; Kim JH
Regul Pept; 2007 Dec; 144(1-3):6-9. PubMed ID: 17706801
[TBL] [Abstract][Full Text] [Related]
13. Repeated d-amphetamine enhances stimulated mesoamygdaloid dopamine transmission.
Harmer CJ; Hitchcott PK; Morutto SL; Phillips GD
Psychopharmacology (Berl); 1997 Aug; 132(3):247-54. PubMed ID: 9292624
[TBL] [Abstract][Full Text] [Related]
14. Induction of a salt appetite alters dendritic morphology in nucleus accumbens and sensitizes rats to amphetamine.
Roitman MF; Na E; Anderson G; Jones TA; Bernstein IL
J Neurosci; 2002 Jun; 22(11):RC225. PubMed ID: 12040084
[TBL] [Abstract][Full Text] [Related]
15. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala.
Nikulina EM; Covington HE; Ganschow L; Hammer RP; Miczek KA
Neuroscience; 2004; 123(4):857-65. PubMed ID: 14751279
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.
Cador M; Bjijou Y; Stinus L
Neuroscience; 1995 Mar; 65(2):385-95. PubMed ID: 7777156
[TBL] [Abstract][Full Text] [Related]
17. A novel procedure for dissociating the anatomical bases of the behavioral effects of amphetamine.
Towell A; Willner P; Muscat R
Pharmacol Biochem Behav; 1987 Nov; 28(3):423-6. PubMed ID: 3685080
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
[TBL] [Abstract][Full Text] [Related]
19. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.
Cohen BM; Cherkerzian S; Ma J; Ye N; Wager C; Lange N
Psychopharmacology (Berl); 2003 Jun; 167(4):403-10. PubMed ID: 12709776
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat.
Mobini S; Chiang TJ; Ho MY; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2000 Sep; 152(1):47-54. PubMed ID: 11041315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
